N
NovaBay Pharmaceuticals, Inc. (NBY)
1.50
0.00 (0.00%)

1.50
0.00 (0.00%)
This stock has a consensus price target of $2.32 based on the ratings of 2 analysts. The high is $3.80 and the low is $0.85.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 0.85 | $ 2.32 | $ 3.8 |
| O’zgarish | -43.33% | 54.67% | 153.33% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2024-11-11 | 183.33% | Ascendiant Capital | $40 → $4.25 | Maintains | Buy |
| 2023-08-11 | 44233.33% | Ladenburg Thalmann | $1050 → $665 | Maintains | Buy |